• LAST PRICE
    2.8700
  • TODAY'S CHANGE (%)
    Trending Up0.1800 (6.6914%)
  • Bid / Lots
    2.8200/ 2
  • Ask / Lots
    2.9000/ 6
  • Open / Previous Close
    2.6000 / 2.6900
  • Day Range
    Low 2.4501
    High 2.9500
  • 52 Week Range
    Low 1.8350
    High 101.2500
  • Volume
    178,762
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 2.69
TimeVolumeTHAR
09:32 ET53592.6
09:33 ET3302.62
09:35 ET69812.5801
09:37 ET19882.6243
09:39 ET26822.58
09:42 ET18402.5816
09:44 ET12702.5408
09:46 ET2452.54
09:48 ET1002.5996
09:50 ET20102.5402
09:51 ET33902.54
09:55 ET27282.4866
09:57 ET25692.5
10:00 ET1902.4637
10:02 ET41002.47
10:04 ET5062.48
10:06 ET13492.5
10:08 ET1002.5
10:09 ET11192.4628
10:11 ET1002.46
10:13 ET2002.4501
10:15 ET2002.4649
10:20 ET7202.4983
10:22 ET20502.4701
10:26 ET19072.53
10:29 ET6002.549
10:33 ET2802.54
10:36 ET2002.54
10:38 ET12632.53
10:40 ET96032.59
10:45 ET1502.5
10:47 ET20442.55
10:51 ET23002.7199
10:56 ET8002.77
11:00 ET4452.76
11:02 ET5612.76
11:03 ET25462.66
11:05 ET14502.71
11:07 ET6202.6842
11:09 ET3502.665
11:12 ET10182.707
11:18 ET2502.7296
11:20 ET1002.7
11:21 ET3002.665
11:23 ET3022.631
11:25 ET1302.7
11:27 ET8002.74
11:32 ET4092.77
11:36 ET2002.6676
11:38 ET11932.74
11:39 ET3002.746046
11:41 ET5002.75
11:43 ET5232.73
11:45 ET77442.74
11:48 ET3002.75
11:54 ET5002.775
11:56 ET2002.765899
12:01 ET13182.75
12:06 ET3002.763
12:08 ET2502.75
12:21 ET7552.76
12:24 ET14452.8
12:26 ET4242.78
12:28 ET10002.8
12:30 ET2102.77
12:32 ET27242.7001
12:42 ET7002.7579
12:48 ET1002.75
12:50 ET81072.82
12:51 ET14002.84
12:53 ET5442.83
12:55 ET24442.86
01:00 ET40722.8946
01:02 ET53082.88
01:04 ET34412.86
01:13 ET1002.78
01:15 ET2002.7801
01:22 ET3022.7888
01:33 ET12662.8191
01:38 ET21132.785
01:40 ET1002.7248
01:42 ET1002.78
01:51 ET10512.79
01:56 ET2492.7899
01:58 ET1002.79
02:02 ET42652.7602
02:03 ET11412.8474
02:05 ET1002.8118
02:07 ET2882.81
02:27 ET2002.78
02:30 ET1002.78
02:36 ET20002.78
02:39 ET8082.85
02:50 ET12002.78
02:54 ET22142.745
02:56 ET11602.72
02:59 ET20832.81
03:08 ET3192.84
03:14 ET1532.85
03:17 ET15012.804857
03:21 ET4092.9
03:24 ET1152.9
03:26 ET1012.9
03:30 ET1002.89
03:32 ET19262.95
03:33 ET30122.9
03:37 ET6172.9
03:39 ET1002.89
03:42 ET1502.87
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTHAR
Tharimmune Inc
3.1M
-0.1x
---
United StatesRASP
Actavia Life Sciences Inc
3.1M
-7.5x
---
United StatesREVB
Revelation Biosciences Inc
3.1M
0.0x
---
United StatesTNFA
TNF Pharmaceuticals Inc
3.2M
-0.2x
---
United StatesSCNI
Scinai Immunotherapeutics Ltd
3.0M
-0.4x
---
United StatesATXI
Avenue Therapeutics Inc
3.2M
-0.7x
---
As of 2024-11-04

Company Information

Tharimmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of therapeutic candidate for inflammatory and immunologic conditions. It has a transmucosal film product, TH104 in Phase I clinical development, two bispecific candidates and a Picobody candidate in pre-clinical development. TH104 is a transmucosal buccal film embedded with the active compound nalmefene onto a thin film which adheres inside of the mouth on the cheek and biodegrades. TH104 is an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. It is also developing an early-stage pipeline of novel therapeutic candidates targeting validated high value immune-oncology (IO) targets including human epidermal growth factor (EGF) receptor 2 (HER2), human EGF receptor 3 (HER3) and programmed cell death protein (PD-1). The Company is developing antibodies, including bispecific antibodies, antibody drug conjugates (ADCs) and others.

Contact Information

Headquarters
1200 Route 22 EastBRIDGEWATER, NJ, United States 08807
Phone
302-743-2995
Fax
302-645-1280

Executives

Chairman of the Board, President, Chief Executive Officer
Randy Milby
Chief Financial Officer
Thomas Hess
Chief Operating Officer, Director
Sireesh Appajosyula
Independent Director
Kelly Anderson
Independent Director
Lynne Bui

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.1M
Revenue (TTM)
$0.00
Shares Outstanding
1.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-55.46
Book Value
$11.67
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.